Page
%P
-
Article
Open AccessSerious haematological toxicity during and after ipilimumab treatment: a case series
Immunotherapy with the anti-cytotoxic T-lymphocyte antigen-4 monoclonal antibody ipilimumab has been shown to improve overall survival in previously treated and treatment-naïve patients with unresectable stage...